Outsourced Drug Discovery Market by Drug Type (Small Molecule Drugs and Large Molecule Drugs), by Services (Preclinical Developments, Target validation and Functional Informatics, Target Identification and Screening, Lead Identification and Candidate Optimization, and Others), by Application (Oncology, Ophthalmology, Hematology, Immunomodulation, Anti-Infective Drugs, Dermatology, Neurology, Cardiology, and Others), by End Users (Pharmaceutical and Biotechnological Companies, Contract research Organization, and  Contract Manufacturing Organization), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2019 - 2026

  • Published On : Jul 2019 |
  • Pages : 157 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Outsourced Drug Discovery Market Insights

Outsourcing is a strategy, by which a pharmaceutical company hires another company such as contract research organization for planned and existing activities including drug discovery, preclinical development, and clinical research. Outsourcing is an agreement between contract research organization and pharmaceutical, biotechnological, and chemical industries. Contract research organizations (CROs) manage almost all aspects of drug discovery including clinical data management, data entry and validation, safety and efficacy summaries, medicine and disease coding, quality and metric reporting, validation programming, statistical analysis plans and reports, and final study report.

The global outsourced drug discovery market was valued at US$ 20.7 billion in 2017, and is expected to witness a CAGR of 12.1% during the forecast period (2019 – 2026).

Figure 1. Global Outsourced Drug Discovery Market Value Analysis (US$ Mn), By Drug Type

Outsourced Drug Discovery  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing number of drug discovery companies is expected to drive growth of the global outsourced drug discovery market

Increasing number of new drug discovery companies is expected to drive the global outsourced drug discovery market growth. For instance, in November 2018, Schrodinger, LLC collaborated with Wuxi AppTec and launched new drug discovery company, Faxian Therapeutics (Headquarter– New York, U.S.). Faxian Therapeutics will utilize the Schrodinger, LLC’s computational platform and WuXi’s drug design and synthesis services to improve health care needs.

Moreover, rising drug discovery services is expected to propel growth of global outsourced drug discovery market. For instance, in April 2019, Eurofins Discovery Services, a contract research organization, launched new drug discovery service DiscoveryOne. The new approach is helpful for the drug discovery research activities and preclinical developments. Hence, launching of services related to drug discovery is expected to support the global outsourced drug discovery market growth.

Global Outsourced Drug Discovery Market- Regional Analysis

North America outsourced drug discovery market is expected to account for the largest market share, owing to business expansion in this region. For instance, in January 2019, Lambda Therapeutic Research (Headquarter-India) acquired Novum Pharmaceutical Research Services, a U.S. CRO. With this acquisition, Lambda Therapeutic Research entered into the U.S. market.

Moreover, Europe is also projected to witness significant growth in the global outsourced drug discovery market, owing to increasing merger and acquisition activities by key players in the region. For instance, in February 2019, Optimapharm, a clinical research organization (CRO) in Europe acquired Denothex, a CRO, for strengthening its presence in the European market particularly in France, Spain, Switzerland, and Italy. Denothex conducts all clinical trials in oncology across Europe and Israel.

Asia Pacific is also projected to witness significant growth in the global outsourced drug discovery market, owing to increasing launches of IT infrastructure investment programs (Trial Management and Monitoring Cloud Service Implementation Program) for development of clinical trials. For instance, in December 2018, Novotech, a CRO, launched new Oracle Trial Management and Monitoring Cloud Service Implementation Program (TMMCS) in Asia-Pacific.TMMCS helps to maintain centralized trial management database and clinical research associate productivity. TMMCS provides various benefits including better trial results, improved investigator relationship, and lower trial costs.

Figure 2: Global Outsourced Drug Discovery Market Share (%), (2018 & 2026) By Region,

Outsourced Drug Discovery  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Global Outsourced Drug Discovery Market - Competitive Landscape

Key players operating in the global outsourced drug discovery market are Aurigene Accelerating Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec AG, Syngene International Ltd., Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia Meditech Co. Ltd.

Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.

Market Dynamics

New strategies adopted by key players related to outsourcing drug discovery is expected to drive growth of global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline (GSK), a British drug manufacturing company collaborated with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR), in San Francisco. The new laboratory will investigate how gene mutations cause diseases, and also develop new technologies using CRISPR to rapidly accelerate the discovery of new medicines.

Furthermore, extension of partnership activities is expected to propel global outsourced drug discovery market growth. For instance, in March 2017, Charles River Laboratories (CRL) extended its partnership with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL) extended its longstanding, strategic, integrated drug discovery program (Respiratory Program). The respiratory program is related to the preclinical drug development for treatment of respiratory diseases and rare diseases.

Key features of the study:

  • This report provides in-depth analysis of the outsourced drug discovery market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2019–2026), considering 2017, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global outsourced drug discovery market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Aurigene Accelerating Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec AG, Syngene International Ltd. Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia Meditech Co. Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global outsourced drug discovery market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Outsourced Drug Discovery  Market, By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
  • Global Outsourced Drug Discovery market, By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
  • Global Outsourced Drug Discovery Market, By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
  • Global Outsourced Drug Discovery market, By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
  • Global Outsourced Drug Discovery market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Drug Type:
        • Small Molecule Drugs
        • Large Molecule Drugs
      • By Services:
        • Preclinical Development
        • Target Validation and Functional Informatics
        • Target Identification and Screening
        • Lead Identification and Candidate Optimization
        • Others
      • By Application
        • Oncology
        • Ophthalmology
        • Hematology
        • Immunomodulation
        • Anti-Infective Drugs
        • Dermatology
        • Pulmonology
        • Cardiology
        • Others
      • By End User
        • Pharmaceutical and Biotechnological Companies
        • Contract Research Organization
        • Contract Manufacturing Organization
    •  Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Drug Type:
        • Small Molecule Drugs
        • Large Molecule Drugs
      • By Services:
        • Preclinical Development
        • Target Validation and Functional Informatics
        • Target Identification and Screening
        • Lead Identification and Candidate Optimization
        • Others
      • By Application
        • Oncology
        • Ophthalmology
        • Hematology
        • Immunomodulation
        • Anti-Infective Drugs
        • Dermatology
        • Pulmonology
        • Cardiology
        • Others
      • By End User
        • Pharmaceutical and Biotechnological Companies
        • Contract Research Organization
        • Contract Manufacturing Organization
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Drug Type:
        • Small Molecule Drugs
        • Large Molecule Drugs
      • By Services:
        • Preclinical Development
        • Target Validation and Functional Informatics
        • Target Identification and Screening
        • Lead Identification and Candidate Optimization
        • Others
      • By Application
        • Oncology
        • Ophthalmology
        • Hematology
        • Immunomodulation
        • Anti-Infective Drugs
        • Dermatology
        • Pulmonology
        • Cardiology
        • Others
      • By End User
        • Pharmaceutical and Biotechnological Companies
        • Contract Research Organization
        • Contract Manufacturing Organization
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Drug Type:
        • Small Molecule Drugs
        • Large Molecule Drugs
      • By Services:
        • Preclinical Development
        • Target Validation and Functional Informatics
        • Target Identification and Screening
        • Lead Identification and Candidate Optimization
        • Others
      • By Application
        • Oncology
        • Ophthalmology
        • Hematology
        • Immunomodulation
        • Anti-Infective Drugs
        • Dermatology
        • Pulmonology
        • Cardiology
        • Others
      • By End User
        • Pharmaceutical and Biotechnological Companies
        • Contract Research Organization
        • Contract Manufacturing Organization
    • Middle East
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
      • By Drug Type:
        • Small Molecule Drugs
        • Large Molecule Drugs
      • By Services:
        • Preclinical Development
        • Target Validation and Functional Informatics
        • Target Identification and Screening
        • Lead Identification and Candidate Optimization
        • Others
      • By Application
        • Oncology
        • Ophthalmology
        • Hematology
        • Immunomodulation
        • Anti-Infective Drugs
        • Dermatology
        • Pulmonology
        • Cardiology
        • Others
      • By End User
        • Pharmaceutical and Biotechnological Companies
        • Contract Research Organization
        • Contract Manufacturing Organization
    •  Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Drug Type:
        • Small Molecule Drugs
        • Large Molecule Drugs
      • By Services:
        • Preclinical Development
        • Target Validation and Functional Informatics
        • Target Identification and Screening
        • Lead Identification and Candidate Optimization
        • Others
      • By Application
        • Oncology
        • Ophthalmology
        • Hematology
        • Immunomodulation
        • Anti-Infective Drugs
        • Dermatology
        • Pulmonology
        • Cardiology
        • Others
      • By End User
        • Pharmaceutical and Biotechnological Companies
        • Contract Research Organization
        • Contract Manufacturing Organization
  • Company Profiles
    • Aurigene Accelerating Discovery,*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Bioduro LLC.
    • Charles River Laboratories (CRL)
    • TCG Lifesciences
    • Evotec AG
    • Syngene International Ltd.
    • Jubilant Biosys Ltd.
    • Pharmaron Inc.
    • Shanghai Medicilon Inc.
    • Sundia Meditech Co. Ltd.
  •  

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Services
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Technology Advancements
    • Historical Overview
    • Merger and Acquisition
    • Regulatory Scenario
    • PORTER’S Five Forces
    • PEST Analysis
  4. Global Outsourced Drug Discovery Market, By Drug Type, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Small Molecule Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Large Molecule Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  5. Global Outsourced Drug Discovery Market, By Services, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Preclinical Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Target Validation and Functional Informatics
      • Introduction                                      
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Target Identification and Screening
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Lead Identification and Candidate Optimization
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Outsourced Drug Discovery Market, By Application, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Ophthalmology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Hematology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Immunomodulation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Anti-Infective Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Dermatology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Neurology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Pulmonology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Cardiology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  7. Global Outsourced Drug Discovery Market, By End Users, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Pharmaceutical and Biotechnological Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Contract Research Organization (CRO)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Contract Manufacturing Organization (CMO)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  8. Global Outsourced Drug Discovery Market, By Region, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Services, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Services, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Services, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Services, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Services, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Million
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Services, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Aurigene Accelerating Discovery
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Bioduro LLC.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Charles River Laboratories (CRL)
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • TCG Lifesciences
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Evotec AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Syngene International Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Jubilant Biosys Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Pharmaron Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Shanghai Medicilon Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
      • Sundia Meditech Co. Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact
  •  

*Browse 23 market data tables and 19 figures on “Outsourced Drug Discovery Market” - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.